Journey Medical Corporation

NasdaqCM:DERM Stock Report

Market Cap: US$107.0m

Journey Medical Balance Sheet Health

Financial Health criteria checks 3/6

Journey Medical has a total shareholder equity of $11.3M and total debt of $22.7M, which brings its debt-to-equity ratio to 201.4%. Its total assets and total liabilities are $65.2M and $53.9M respectively. Journey Medical's EBIT is $2.1M making its interest coverage ratio 2.3. It has cash and short-term investments of $23.9M.

Key information

201.4%

Debt to equity ratio

US$22.75m

Debt

Interest coverage ratio2.3x
CashUS$23.91m
EquityUS$11.30m
Total liabilitiesUS$53.89m
Total assetsUS$65.19m

Recent financial health updates

Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden

Sep 14
Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden

Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?

May 06
Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?

Recent updates

Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden

Sep 14
Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden

Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?

May 06
Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?

Journey Medical Corporation (NASDAQ:DERM) Not Doing Enough For Some Investors As Its Shares Slump 31%

Mar 11
Journey Medical Corporation (NASDAQ:DERM) Not Doing Enough For Some Investors As Its Shares Slump 31%

Journey Medical Corporation's (NASDAQ:DERM) 33% Dip In Price Shows Sentiment Is Matching Revenues

Jan 18
Journey Medical Corporation's (NASDAQ:DERM) 33% Dip In Price Shows Sentiment Is Matching Revenues

Journey Medical Corporation's (NASDAQ:DERM) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Nov 10
Journey Medical Corporation's (NASDAQ:DERM) Price Is Right But Growth Is Lacking After Shares Rocket 26%

US$12.00: That's What Analysts Think Journey Medical Corporation (NASDAQ:DERM) Is Worth After Its Latest Results

May 12
US$12.00: That's What Analysts Think Journey Medical Corporation (NASDAQ:DERM) Is Worth After Its Latest Results

Financial Position Analysis

Short Term Liabilities: DERM's short term assets ($46.5M) exceed its short term liabilities ($34.1M).

Long Term Liabilities: DERM's short term assets ($46.5M) exceed its long term liabilities ($19.7M).


Debt to Equity History and Analysis

Debt Level: DERM has more cash than its total debt.

Reducing Debt: Insufficient data to determine if DERM's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: DERM's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: DERM's interest payments on its debt are not well covered by EBIT (2.3x coverage).


Balance Sheet


Discover healthy companies